Turn8 Private Wealth’s Biogen BIIB Stock Holding History

Turn8 Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Buy	+12,068	New	+$2.31M	1.69%	25

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Turn8 Private Wealth's BIIB Position: Q2 2026 in Review

Turn8 Private Wealth opened a new position in Biogen (BIIB) in Q2 2026: 12,068 shares worth $2.53M. The stake represents 1.69% of the portfolio and ranks #25 among its holdings.

1,034 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Turn8 Private Wealth held 12,068 shares of Biogen worth $2.53M as of Q2 2026.
Biogen was a new Turn8 Private Wealth position in Q2 2026.
Biogen made up 1.69% of Turn8 Private Wealth's portfolio in Q2 2026, its #25 holding.
1,034 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Turn8 Private Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.